Transplantation, Autologous
"Transplantation, Autologous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation of an individual's own tissue from one site to another site.
| Descriptor ID |
D014182
|
| MeSH Number(s) |
E04.936.664
|
| Concept/Terms |
Transplantation, Autologous- Transplantation, Autologous
- Autotransplantation
- Autotransplantations
- Autografting
- Autograftings
- Autologous Transplantation
- Autologous Transplantations
- Transplantations, Autologous
|
Below are MeSH descriptors whose meaning is more general than "Transplantation, Autologous".
Below are MeSH descriptors whose meaning is more specific than "Transplantation, Autologous".
This graph shows the total number of publications written about "Transplantation, Autologous" by people in this website by year, and whether "Transplantation, Autologous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 6 | 6 |
| 1998 | 0 | 6 | 6 |
| 1999 | 2 | 7 | 9 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 7 | 7 |
| 2002 | 2 | 6 | 8 |
| 2003 | 0 | 10 | 10 |
| 2004 | 0 | 6 | 6 |
| 2005 | 2 | 4 | 6 |
| 2006 | 1 | 8 | 9 |
| 2007 | 0 | 5 | 5 |
| 2008 | 1 | 10 | 11 |
| 2009 | 2 | 6 | 8 |
| 2010 | 0 | 5 | 5 |
| 2011 | 0 | 7 | 7 |
| 2012 | 0 | 4 | 4 |
| 2013 | 0 | 10 | 10 |
| 2014 | 3 | 4 | 7 |
| 2015 | 0 | 8 | 8 |
| 2016 | 0 | 3 | 3 |
| 2017 | 1 | 10 | 11 |
| 2018 | 0 | 10 | 10 |
| 2019 | 2 | 6 | 8 |
| 2020 | 0 | 9 | 9 |
| 2021 | 2 | 25 | 27 |
| 2022 | 0 | 9 | 9 |
| 2023 | 0 | 5 | 5 |
| 2024 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplantation, Autologous" by people in Profiles.
-
High-Dose Chemotherapy and Autologous or Allogeneic Transplantation in Aggressive B-Cell Lymphoma-Is There Still a Role? Cells. 2024 Oct 27; 13(21).
-
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission. Blood Cancer J. 2024 07 08; 14(1):108.
-
Rilparencel (Renal Autologous Cell Therapy-REACT®) for Chronic Kidney Disease and Type 1 and Type 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Redosing Triggers. Am J Nephrol. 2024; 55(3):389-398.
-
Late Pulmonary Autograft Dilation: Can We Make a Good Operation Great? The Tailored Approach. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2024; 27:42-46.
-
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401. Clin Cancer Res. 2023 12 01; 29(23):4784-4796.
-
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial. Br J Haematol. 2023 12; 203(5):792-802.
-
Improved Quality of Life Among Chronic Pancreatitis Patients Undergoing Total Pancreatectomy With Islet Autotransplantation-Single Center Experience With Large Cohort of Patients. Transpl Int. 2023; 36:11409.
-
Nutritional Risks in Patients Undergoing Total Pancreatectomy Islet AutoTransplantation in the POST Consortium. J Gastrointest Surg. 2023 09; 27(9):1893-1902.
-
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial. Lancet Oncol. 2023 02; 24(2):139-150.
-
Commentary on: Supplementation of Facial Fat Grafting to Increase Volume Retention: A Systematic Review. Aesthet Surg J. 2022 12 14; 42(12):NP728-NP729.